NAT10 and neoplasm: To determine whether targeting NAT10-induced vascular normalization could effectively promote immune reprogramming within the tumor microenvironment, we employed flow cytometry analysis and immunofluorescence (IF) staining to analyze the infiltrating immune cell populations in tumors treated with Remodelin.